Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes
- PMID: 38856793
- DOI: 10.1007/s12035-024-04260-y
Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes
Abstract
Neurodegenerative illnesses (NDDs) like Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, spinal muscular atrophy, and Huntington's disease have demonstrated considerable potential for gene therapy as a viable therapeutic intervention. NDDs are marked by the decline of neurons, resulting in changes in both behavior and pathology within the body. Strikingly, only symptomatic management is available without a cure for the NDDs. There is an unmet need for a permanent therapeutic approach. Many studies have been going on to target the newer therapeutic molecular targets for NDDs including gene-based therapy. Gene therapy has the potential to provide therapeutic benefits to a large number of patients with NDDs by offering mechanisms including neuroprotection, neuro-restoration, and rectification of pathogenic pathways. Gene therapy is a medical approach that aims to modify the biological characteristics of living cells by controlling the expression of specific genes in certain neurological disorders. Despite being the most complex and well-protected organ in the human body, there is clinical evidence to show that it is possible to specifically target the central nervous system (CNS). This provides hope for the prospective application of gene therapy in treating NDDs in the future. There are several advanced techniques available for using viral or non-viral vectors to deliver the therapeutic gene to the afflicted region. Neurotrophic factors (NTF) in the brain are crucial for the development, differentiation, and survival of neurons in the CNS, making them important in the context of various neurological illnesses. Gene delivery of NTF has the potential to be used as a therapeutic approach for the treatment of neurological problems in the brain. This review primarily focuses on the methodologies employed for delivering the genes of different NTFs to treat neurological disorders. These techniques are currently being explored as a viable therapeutic approach for neurodegenerative diseases. The article exclusively addresses gene delivery approaches and does not cover additional therapy strategies for NDDs. Gene therapy offers a promising alternative treatment for NDDs by stimulating neuronal growth instead of solely relying on symptom relief from drugs and their associated adverse effects. It can serve as a long-lasting and advantageous treatment choice for the management of NDDs. The likelihood of developing NDDs increases with age as a result of neuronal degradation in the brain. Gene therapy is an optimal approach for promoting neuronal growth through the introduction of nerve growth factor genes.
Keywords: Gene therapy; Gene-delivering techniques; Neurodegenerative disorders; Neurotrophic factors; Novel approaches.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
Similar articles
-
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.Pharmacol Res. 2010 Jan;61(1):14-26. doi: 10.1016/j.phrs.2009.10.002. Epub 2009 Oct 17. Pharmacol Res. 2010. PMID: 19840853 Free PMC article. Review.
-
Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.Mol Neurobiol. 2022 Jan;59(1):191-233. doi: 10.1007/s12035-021-02555-y. Epub 2021 Oct 15. Mol Neurobiol. 2022. PMID: 34655056 Free PMC article. Review.
-
Progress in the mechanisms of pain associated with neurodegenerative diseases.Ageing Res Rev. 2024 Dec;102:102579. doi: 10.1016/j.arr.2024.102579. Epub 2024 Nov 13. Ageing Res Rev. 2024. PMID: 39542176 Review.
-
Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.Curr Gene Ther. 2017;17(2):170-183. doi: 10.2174/1566523217666170510153845. Curr Gene Ther. 2017. PMID: 28494742 Review.
-
Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.J Neuroimmune Pharmacol. 2017 Mar;12(1):51-83. doi: 10.1007/s11481-016-9724-3. Epub 2017 Feb 3. J Neuroimmune Pharmacol. 2017. PMID: 28160121 Free PMC article. Review.
Cited by
-
Xanthine Oxidoreductase: A Double-Edged Sword in Neurological Diseases.Antioxidants (Basel). 2025 Apr 17;14(4):483. doi: 10.3390/antiox14040483. Antioxidants (Basel). 2025. PMID: 40298821 Free PMC article. Review.
-
Adaptive immunity in the pathogenesis and treatments of Parkinson's disease.NeuroImmune Pharm Ther. 2025 Jun 20;4(2):273-284. doi: 10.1515/nipt-2025-0008. eCollection 2025 Jun. NeuroImmune Pharm Ther. 2025. PMID: 40740678 Free PMC article. Review.
-
The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.J Clin Med. 2025 Jan 9;14(2):386. doi: 10.3390/jcm14020386. J Clin Med. 2025. PMID: 39860392 Free PMC article. Review.
-
Primary Progressive Multiple Sclerosis: New Therapeutic Approaches.Neuropsychopharmacol Rep. 2025 Sep;45(3):e70039. doi: 10.1002/npr2.70039. Neuropsychopharmacol Rep. 2025. PMID: 40653594 Free PMC article. Review.
References
-
- Dugger BN, Dickson DW (2016) cshperspect-PRI-a028035.pdf. Cold Spring harb Persepect biol 9:1–22
-
- Lamptey RNL, Chaulagain B, Trivedi R et al (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23. https://doi.org/10.3390/ijms23031851
-
- Pathak N, Vimal SK, Tandon I et al (2022) Neurodegenerative disorders of Alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment. Metab Brain Dis 37:67–104. https://doi.org/10.1007/s11011-021-00800-w - DOI - PubMed
-
- Sudhakar V, Richardson RM (2019) Gene therapy for neurodegenerative diseases. Neurotherapeutics 16:166–175. https://doi.org/10.1007/s13311-018-00694-0 - DOI - PubMed
-
- Kaji EH, Leiden JM (2001) Gene and stem cell therapies. JAMA 285:545–550. https://doi.org/10.1001/jama.285.5.545 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical